Walleye Trading’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Walleye Trading’s Portfolio CMRAW Stock Details CMRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-34,848	Closed	-$756	–	5682
2023 Q3	$756	Hold	34,848	–	–	﹤0.01%	4895
2023 Q2	$944	Hold	34,848	–	–	﹤0.01%	4580
2023 Q1	$1.5K	Hold	34,848	–	–	﹤0.01%	4686
2022 Q4	$1.66K	Hold	34,848	–	–	﹤0.01%	4754
2022 Q3	$2K	Hold	34,848	–	–	﹤0.01%	4828
2022 Q2	$5K	Buy	+34,848	New	+$5.71K	﹤0.01%	4798

Other funds holding CMRAW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Walleye Trading's CMRAW Position: Q4 2023 in Review

Walleye Trading sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q4 2023, closing a stake of 34,848 shares — an estimated $756 sold.

Walleye Trading first reported a position in CMRAW in Q2 2022 and held it in 6 quarters. The position peaked at $5K in Q2 2022. 3 funds tracked by Wall St. Rank hold CMRAW as of Q4 2023.

Walleye Trading reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q4 2023 after selling out during the quarter.
Walleye Trading sold 34,848 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q4 2023, an estimated $756.
Walleye Trading first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 6 quarters.
Walleye Trading's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $5K in Q2 2022.
3 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.